|

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

RECRUITINGSponsored by University Hospital, Toulouse
Actively Recruiting
SponsorUniversity Hospital, Toulouse
Started2023-11-16
Est. completion2035-01-31
Eligibility
Age18 Years – 120 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06128343

Summary

BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.

Eligibility

Age: 18 Years – 120 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
* Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
* Patient with pancreatic adenocarcinoma proven histologically and/or cytologically

Exclusion Criteria:

* Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
* Pregnant or breastfeeding patient

Conditions4

AdenocarcinomaCancerCarcinomaNeoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.